Abood R R
Wyoming Pharmaceutical Association, School of Pharmacy, University of Wyoming.
Am J Law Med. 1989;14(4):307-52.
Despite the fact that physicians have dispensed prescription drugs for profit for several years, the practice is currently under intense challenge and controversy. This recent flare-up can be explained by several factors including the involvement of the Federal Trade Commission (FTC), increased competition among physicians, alternative delivery systems and drug repackagers. Federal laws including the Food Drug and Cosmetic Act and Controlled Substances Act regulate dispensing practices, but have been interpreted to regulate dispensing by pharmacists, not physicians. All states have laws applicable to the dispensing of prescription drugs by physicians, but the wording of these laws raises unclear legal issues. Both uncertainty about these legal issues and pharmacists' concern over the increase in physician dispensing has promoted state legislative efforts to restrict or regulate the practice. These legislative efforts and the corresponding regulatory actions by state boards have triggered FTC involvement. From a social policy perspective physician dispensing raises significant concerns of ethics, conflicts of interest, patient welfare and economics. Based upon social policy, physician dispensing for profit is not a practice which should be condoned or allowed to flourish.
尽管医生为了盈利而配发处方药已有数年时间，但目前这种做法正面临着激烈的挑战和争议。近期这种情况的突然爆发可以由几个因素来解释，包括联邦贸易委员会（FTC）的介入、医生之间竞争的加剧、替代给药系统以及药品重新包装商。包括《食品药品和化妆品法案》以及《管制物质法案》在内的联邦法律对配药行为进行规范，但这些法律被解释为是对药剂师配药行为的规范，而非医生。所有州都有适用于医生配发处方药的法律，但这些法律的措辞引发了不明确的法律问题。这些法律问题的不确定性以及药剂师对医生配药增加的担忧，促使各州进行立法努力以限制或规范这种做法。这些立法努力以及州委员会相应的监管行动引发了联邦贸易委员会的介入。从社会政策的角度来看，医生配药引发了对伦理、利益冲突、患者福利和经济等方面的重大担忧。基于社会政策，医生为了盈利而配药并非一种应该被容忍或任其发展的做法。
